Ketamine Nasal Spray Approved as Standalone Treatment for Tough Depression Cases
An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other options.
Even light-intensity activities such as walking can reduce one’s risk for clinical depression. So, what are the most common ...
Blue Monday originated from a publicity stunt, but seasonal affective disorder is a real affliction that affects millions of ...
Part of you is concerned — after all, you know depression can be serious — but on the other hand, can’t weight loss be a good ...
A study shows a chain: low emotional clarity is linked to depression, and this clarity is influenced by higher inflammation ...
It's become increasingly clear that the gut microbiome can affect human health, including mental health. Which bacterial ...
A new report studied depression levels across Europe and in older and younger individuals, with the outlook for France ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback